Adjuvant IFN alpha2 therapy of melanoma
- PMID: 9654253
- DOI: 10.1016/S0140-6736(05)78608-6
Adjuvant IFN alpha2 therapy of melanoma
Comment in
-
Adjuvant therapy of melanoma.Lancet. 1998 Aug 29;352(9129):737-8. doi: 10.1016/S0140-6736(05)60856-2. Lancet. 1998. PMID: 9729017 No abstract available.
-
Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma.Lancet. 1998 Sep 12;352(9131):908-9. doi: 10.1016/s0140-6736(05)60052-9. Lancet. 1998. PMID: 9743016 No abstract available.
Comment on
-
Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma.Lancet. 1998 Jun 27;351(9120):1905-10. doi: 10.1016/s0140-6736(97)12445-x. Lancet. 1998. PMID: 9654256 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
